Web1 day ago · Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2024 after market close on Tuesday, May 2, 2024. ... Investor Relations [email protected]. Data & News supplied by www.cloudquote.io … Web23 hours ago · Investor Relations ... Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment …
Omnicell, Inc. Common Stock ($0.001 par value) (OMCL) - Nasdaq
Web1 day ago · Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2024 after market close on Tuesday, May 2, 2024. ... Investor Relations [email protected]. Data & News supplied by www.cloudquote.io … Web05. apr 2024. · Omnicell to Release First Quarter 2024 Financial Results on April 28, 2024. April 05, 2024 04:01 PM Eastern Daylight Time. MOUNTAIN VIEW, Calif.-- ( BUSINESS … hephaistos funktion
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Rating of …
Web01. maj 2024. · Omnicell, Inc. (NASDAQ:NASDAQ:OMCL) Q1 2024 Earnings Conference Call April 28, 2024 4:30 PM ETCompany ParticipantsRandall Lipps - Chairman, … Web28. feb 2024. · Investor Relations. Omnicell is transforming the pharmacy care delivery model, dramatically improving outcomes and lowering costs through a combination of … Blog Careers myOmnicell Investor Relations USA + Canada . Enhance … SEC Filings. Date Filing Type Filing Description Download / View. February … Web14. apr 2024. · Shares of OMCL opened at $61.47 on Friday. The stock has a market cap of $2.77 billion, a price-to-earnings ratio of 614.70, a P/E/G ratio of 8.23 and a beta of 0.90. The company has a quick ratio ... hephaistos jumal